Lidocaine/Chlorhexidine Acetate/benzalkonium bromide

利多卡因/醋酸氯己定/苯扎溴铵

Report date: 2026/02/13 10:40:20
NME

Base Information

Drug NameLidocaine/Chlorhexidine Acetate/benzalkonium bromide
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSodium channels blockersCell wall inhibitors
TargetsSodium channels
Therapy Area/IndicationsWounds and InjuriesBites and StingsMiliaria +[4] 
Global Approved IndicationsWounds and InjuriesBites and StingsMiliaria +[4] 
Approved Indications in ChinaWounds and InjuriesBites and StingsMiliaria +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1994/01/01
Country/TerritoryMainland China
CombinationsYes LidocaineChlorhexidine AcetateBenzalkonium bromide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Baiyunshan Pharmaceutical Co Ltd Baiyunshan External Medicine Factory
Inactive CompaniesN/A
Active IndicationsBites and StingsMiliariaPruritus
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeD08AC52N01BB52
Related LinksN/A